Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label serous. Show all posts
Showing posts with label serous. Show all posts
Saturday, April 21, 2012

abstract: Hormone Therapy and Different Ovarian Cancers: A National Cohort Study (postmenopausal women/does not include reference to clear cell ovarian)

›
  Blogger's Note: the abstract makes no reference to clear cell ovarian, given the number of women followed this omission (in the abstr...
Sunday, April 15, 2012

abstract: Validation of an Algorithm for the Diagnosis of Serous Tubal Intraepithelial Carcinoma.

›
Validation of an Algorithm for the Diagnosis of Serous Tubal Intraepithelial Carcinoma Abstract It has been reported that the diagnos...

abstract: Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type.

›
Endometriosis does not confer improved prognosis in ovarian carcinoma of uniform cell type [Am J Surg Pathol. 2012] Abstract The role...
Saturday, March 31, 2012

(Apr 2012) Commentary: Link between endometriosis and ovarian-cancer subtypes : The Lancet Oncology

›
Link between endometriosis and ovarian-cancer subtypes : The Lancet Oncology "Previous large epidemiological studies have attempte...
Tuesday, March 27, 2012

open access: Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer — NEJM

›
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer — NEJM ......"We evaluated the efficacy of olaparib monoth...
Monday, February 27, 2012

open access: JTM - Absolute lymphocyte count is associated with survival in ovarian (SEROUS) cancer independent of tumor-infiltrating lymphocytes

›
  lymphocytes plural of lym·pho·cyte Noun : A form of small leukocyte (white blood cell) with a single round nucleus, occurring esp....
Wednesday, January 11, 2012

Medscape: Aurora-B Protein Expression in Stage III Ovarian Carcinoma

›
"Aims Aurora kinases are central to cell proliferation and considered to be prognostic/predictive markers and therapeutic targets fo...
Tuesday, January 10, 2012

phase 11 - Cancer Research UK launches 'outpatients' (oral)trial of breast and ovarian cancer drug (BRCA/serous cell type - AG-014699 known as Rucaparib or CO-338 - PARP inhibitor)

›
" Cancer Research UK’s Drug Development Office has re-launched a trial of a promising drug to treat inherited breast and ovarian can...

Prognostic significance of L1CAM in ovarian (serous) cancer and its role in constitutive NF-κB activation

›
Background: Overexpression of L1-cell adhesion molecule (L1CAM) has been observed for various carcinomas and correlates with poor prognos...
Friday, January 06, 2012

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

›
Background: Previously, small studies have found that BRCA1 and BRCA2 breast tumors differ in their pathology. Analysis of larger datas...
Saturday, December 31, 2011

Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer

›
Highlights ► Androgen receptor expression correlates with androgen sensitivity in ovarian cancer. ► Androgen receptor expression de...
Thursday, August 04, 2011

Cancer Genome Atlas (press release July 2011) TCGA Completes Ovarian Cancer (serous) Analysis - TCGA plus link to video discussion

›
To view a video of Dr. Spellman discussing TCGA and the ovarian cancer findings, please go to http://www.youtube.com/watch?v=TK_CIGEUHxU
Wednesday, August 03, 2011

p53 Signature and Serous Tubal In-situ Carcinoma in Cases of Primary Tubal and Peritoneal Carcinomas and Serous Borderline Tumors of the Ovary

›
Thursday, June 30, 2011

press release: UCSF-led team decodes evolution of skin and ovarian cancer cells (squamous cell/serous cell)

›
"They worked with a type of skin cancer known as cutaneous squamous cell carcinoma, which has among the highest numbers of mutations o...
Wednesday, June 29, 2011

The Cancer Genome Atlas completes detailed ovarian cancer analysis - GenOmics

›
also: A more detailed press release on the study will be available from the National Institutes of Health at http://nih.gov/news/ .
Friday, May 06, 2011

full free access: Recent surgical management of ovarian cancer - Journal of Obstetrics and Gynaecology Research

›
Abstract (also full free access): Ovarian cancer is the second most common gynecological malignancy in the USA, and the majority of patient...
Thursday, March 17, 2011

full free access: PLoS ONE: Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease Pathogenesis (Mar 15/2011)

›
Note: research/technical/primary focus on serous cell type
Wednesday, February 16, 2011

abstract: Tubal ligation and the risk of ovarian cancer: review and meta-analysis — Hum Reprod Update (serous/mucinous/endometrioid)

›
BACKGROUND The reduction of ovarian cancer (OC) risk in women with a history of tubal ligation (TL) has been reported repeatedly , mo...
Monday, September 27, 2010

Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases

›
Abstract Previous studies in Western countries have revealed that mucosal carcinoma of the fallopian tube frequently coexists with pelvic ...
Monday, August 23, 2010

Serous and mucinous borderline ovarian tumors (LMP): are there real differences between these two entities?

›
Objective To evaluate the clinical outcome and pathological features of patients with borderline ovarian tumors (BOT) with special emphasis...